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Background: The aim was to describe the management of benign gallbladder disease and identify
characteristics associated with all-cause 30-day readmissions and complications in a prospective
population-based cohort.
Methods: Data were collected on consecutive patients undergoing cholecystectomy in acuteUK and Irish
hospitals between 1 March and 1 May 2014. Potential explanatory variables influencing all-cause 30-day
readmissions and complications were analysed by means of multilevel, multivariable logistic regression
modelling using a two-level hierarchical structure with patients (level 1) nested within hospitals (level 2).
Results: Data were collected on 8909 patients undergoing cholecystectomy from 167 hospitals. Some
1451 cholecystectomies (16⋅3 per cent) were performed as an emergency, 4165 (46⋅8 per cent) as elective
operations, and 3293 patients (37⋅0 per cent) had had at least one previous emergency admission,
but had surgery on a delayed basis. The readmission and complication rates at 30 days were 7⋅1 per
cent (633 of 8909) and 10⋅8 per cent (962 of 8909) respectively. Both readmissions and complications
were independently associated with increasing ASA fitness grade, duration of surgery, and increasing
numbers of emergency admissions with gallbladder disease before cholecystectomy. No identifiable
hospital characteristics were linked to readmissions and complications.
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Introduction
Benign gallbladder disease is amajor global health burden1.
It is estimated that for every 100 000 of the world’s popu-
lation, 115 patients undergo cholecystectomy every year.
In England alone, approximately 70 000 cholecystectomies
are performed annually2. Among those fit for surgery,
patients follow one of three pathways from presentation
to definitive treatment linked to emergency admissions
with gallbladder disease: emergency cholecystectomy dur-
ing an emergency admission; elective cholecystectomywith
no previous emergency admission; or delayed cholecystec-
tomy following one or more previous emergency admis-
sions with gallbladder pathology.
Variations in outcomes exist following these different
patient pathways. When performed with no previous
emergency admission, either as an index emergency or
elective operation, cholecystectomy is associated with
fewer gallbladder-specific complications, a shorter total
length of hospital stay and similar operative complications
compared with those among patients who have had one
or more emergency admissions3–5. Many of these studies
were conducted in specialized centres by enthusiasts. In
contrast, population-level data from Hospital Episode
Statistics (HES)2 and a retrospective study from Scotland6
both suggested that emergency cholecystectomy may be
associated with poorer surgical outcomes. The reasons for
these differences are unclear, but may be due to patient,
disease, surgical and hospital variables not fully realized in
administrative data sets.
Patient outcomes are used to measure quality of health-
care, such as readmission, complication, reoperation and
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mortality rates6–13. The mortality rate is low following
cholecystectomy, and therefore a poor measure of quality
in this cohort14. In contrast, reducing hospital readmis-
sions and complications after surgery can lower hospital
costs and improve patient satisfaction15–17. The causes of
readmission and complications after cholecystectomy have
been poorly studied in large prospective series, but may
vary according to patient pathways11.
Over the past 8 years, trainee-led networks in the
UK have adopted a collaborative approach to deliver
prospective population-level data collection, and mea-
sure patient, disease, surgical and hospital variables
with short-term endpoints such as readmissions and
complications18. Using these networks, a prospective,
population-based cohort study was conducted to describe
management of patients with benign gallbladder disease19,
and identify patient, disease, surgical and hospital-related
characteristics that might be associated with all-cause
30-day readmission and complications.
Methods
The study was carried out as described previously19.
The study protocol did not require research registration
as anonymized, observational data were collected. This
was confirmed by the online National Research Ethics
Service decision tool (http://www.hra-decisiontools.org.
uk/research/), and further supported by written confir-
mation and advice from the Research and Development
Director at University Hospitals Birmingham NHS Foun-
dation Trust, UK. The study was registered as a clinical
audit or service evaluation at each participating hospital
under the supervision of a named senior investigator
(consultant surgeon).
Inclusion and exclusion criteria
All patients undergoing cholecystectomy for benign
gallbladder diseases in acute UK and Irish hospitals par-
ticipating in this study between 1 March and 1 May 2014
were included. Patients were grouped according to the
timing of cholecystectomy: emergency cholecystectomy,
defined as cholecystectomy during an emergency admis-
sion; delayed cholecystectomy, defined as a scheduled
cholecystectomy following an emergency admission with
gallbladder disease in the preceding 12 months; or elective
cholecystectomy, defined as a planned elective admission
for cholecystectomy following referral by a family doctor
and addition to the routine surgical waiting list from
an outpatient department visit. Open, laparoscopic, and
laparoscopic procedures converted to open surgery were
included. Cholecystectomies for a known gallbladder
cancer or as a part of another surgical procedure (such as
pancreaticoduodenectomy) were excluded.
Outcome measures
Planned analyses comprised a description of current man-
agement of benign gallbladder disease with readmission
and complication rates. Variations in 30-day complication
and readmission rates were studied as well as predictive
factors for these events. A list of recorded complications
with their definitions is available in Appendix S1 (support-
ing information).
Data quality
To standardize data quality, a quality assurance programme
was developed19. This included a detailed study proto-
col, pilot phase, and a requirement for a minimum of 95
per cent data completeness at submission. Case ascertain-
ment, including readmission to a different hospital from
that in which cholecystectomy was performed, and data
accuracy, were validated by independent investigators at
selected hospitals, who checked data from 10 per cent of
patients against original medical records. These indepen-
dent investigators were not involved in the original data
collection.
Explanatory variables
Patient, disease and hospital characteristics were consid-
ered as potential explanatory variables influencing the
performance of emergency cholecystectomy. A full list
including definitions has been published previously19.
Briefly, patient characteristics included: age, sex, ASA
fitness grade (I, normal healthy patient; II, mild systemic
disease; III, severe systemic disease; IV, severe systemic
disease that is a constant threat to life; V, moribund patient
who is not expected to survive without the operation) and
BMI (less than 17⋅9 kg/m2, underweight; 18⋅0–24⋅9 kg/m2,
normal; 25⋅0–29⋅9 kg/m2, overweight; 30⋅0–34⋅9 kg/m2,
moderate obesity; 35⋅0 kg/m2 and above, severe or very
severe obesity). The following disease characteristics
were considered: indication (biliary colic, cholecystitis,
pancreatitis, common bile duct (CBD) stones), ultrasound
findings (gallbladder wall thickness, dilated CBD), findings
from other radiological investigations (CT,magnetic retro-
grade cholangiopancreatography (MRCP), endoscopic
retrograde cholangiopancreatography (ERCP)) and total
number of emergency admissions with biliary symptoms
in the 12 months before cholecystectomy.
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Table 1 Patient and disease characteristics, and radiological investigations according to performance of emergency, delayed or elective
cholecystectomy
All patients
(n=8909)
Emergency cholecystectomy
(n=1451)
Delayed cholecystectomy
(n=3293)
Elective cholecystectomy
(n=4165) P**
Age (years) < 0⋅001
<40 2534 (28⋅4) 441 (30⋅4) 859 (26⋅1) 1234 (29⋅6)
40–60 3531 (39⋅6) 510 (35⋅1) 1161 (35⋅3) 1860 (44⋅7)
61–80 2602 (29⋅2) 435 (30⋅0) 1108 (33⋅6) 1059 (25⋅4)
>80 242 (2⋅7) 65 (4⋅5) 165 (5⋅0) 12 (0⋅3)
Sex < 0⋅001
F 6565 (73⋅7) 1000 (68⋅9) 2189 (66⋅5) 3376 (81⋅1)
M 2344 (26⋅3) 451 (31⋅1) 1104 (33⋅5) 789 (18⋅9)
BMI (kg/m2) 0⋅033
<17⋅9 41 (0⋅5) 6 (0⋅4) 17 (0⋅5) 18 (0⋅5)
18⋅0–24⋅9 1749 (20⋅6) 262 (19⋅4) 667 (21⋅1) 820 (20⋅5)
25⋅0–29⋅9 3031 (35⋅7) 494 (36⋅6) 1108 (35⋅1) 1429 (35⋅8)
30⋅0–34⋅9 2078 (24⋅4) 337 (25⋅0) 805 (25⋅5) 936 (23⋅4)
≥35⋅0 1600 (18⋅8) 250 (18⋅5) 560 (17⋅7) 790 (19⋅8)
Unknown 410 102 136 172
ASA fitness grade < 0⋅001
I–II 7897 (89⋅4) 1220 (85⋅0) 2873 (87⋅9) 3804 (92⋅1)
≥ III 937 (10⋅6) 216 (15⋅0) 396 (12⋅1) 325 (7⋅9)
Unknown 75 15 24 36
Indication <0⋅001
Colic 4683 (52⋅6) 295 (20⋅3) 955 (29⋅0) 3433 (82⋅5)
Cholecystitis 2581 (29⋅0) 795 (54⋅8) 1369 (41⋅6) 417 (10⋅0)
Pancreatitis 851 (9⋅6) 268 (18⋅5) 545 (16⋅6) 38 (0⋅9)
CBD stone 589 (6⋅6) 83 (5⋅7) 386 (11⋅7) 120 (2⋅9)
Polyp 135 (1⋅5) 2 (0⋅1) 16 (0⋅5) 117 (2⋅8)
Dyskinesia 31 (0⋅3) 1 (0⋅1) 9 (0⋅3) 21 (0⋅5)
Acalculous 28 (0⋅3) 6 (0⋅4) 11 (0⋅3) 11 (0⋅3)
Other 2 (0⋅0) 0 (0) 0 (0) 2 (0⋅0)
Missing 9 1 2 6
No. of admissions before surgery < 0⋅001
0 5196 (58⋅3) 913 (62⋅9) 118 (3⋅6) 4165 (100)
1 2859 (32⋅1) 361 (24⋅9) 2498 (75⋅9) 0 (0)
2 623 (7⋅0) 121 (8⋅3) 502 (15⋅2) 0 (0)
≥3 231 (2⋅6) 56 (3⋅9) 175 (5⋅3) 0 (0)
Ultrasonography performed 8539 (96⋅0)*
Ultrasound findings
Thick-walled 2855 (32⋅8)† 729 (51⋅9) 1412 (43⋅6) 714 (17⋅6) < 0⋅001
CBD dilated 1398 (16⋅0)‡ 289 (20⋅6) 793 (24⋅5) 316 (7⋅8) <0⋅001
CT performed 1307 (14⋅8)§ 290 (20⋅1) 680 (20⋅8) 337 (8⋅2) <0⋅001
MRCP performed 2301 (26⋅1)¶ 417 (28⋅9) 1319 (40⋅2) 565 (13⋅8) < 0⋅001
ERCP performed 960 (10⋅9)# 139 (9⋅6) 670 (20⋅5) 151 (3⋅7) <0⋅001
Values in parentheses are percentages. CBD, common bile duct; MRCP, magnetic retrograde cholangiopancreatography; ERCP, endoscopic retrograde
cholangiopancreatography. Data missing for *12, †219, ‡212, §101, ¶93 and #105 patients. **χ2 test or Fisher’s exact test, as appropriate.
Surgical characteristics included degree of difficulty
according to the Nassar score20 and surgical approach
(laparoscopic, open, or laparoscopic converted to open
surgery). Hospital characteristics, including type (uni-
versity or not), specialist hepatobiliary centre and acute
hospital status, were recorded along with the number
of consultants within the reporting hospital perform-
ing cholecystectomy, hospital country, number of beds
within the reporting hospital (fewer than 100, 101–500,
501–1000, more than 1000) and presence of an on-site
ERCP service. The hospital’s policy regarding the ease
of performing intraoperative cholangiography and use
of dedicated emergency gallbladder operating lists were
considered. The consultant’s presence, specialty and grade
were also recorded at the time of cholecystectomy.
Statistical analysis
Results are reported in accordance with the STROBE
statement for observational studies21. Crude rates of
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Table 2 Surgical and hospital-related factors in 8909 cholecystectomies according to performance of emergency, delayed or elective
cholecystectomy
All patients
(n=8909)
Emergency cholecystectomy
(n=1451)
Delayed cholecystectomy
(n=3293)
Elective cholecystectomy
(n=4165) P‡
Grade of operating surgeon
Junior trainee 403 (4⋅5) 91 (6⋅3) 114 (3⋅5) 198 (4⋅8) < 0⋅001
Senior trainee 1488 (16⋅7) 278 (19⋅2) 503 (15⋅3) 707 (17⋅0) < 0⋅001
Consultant 7007 (78⋅7) 1080 (74⋅5) 2675 (81⋅3) 3252 (78⋅2) < 0⋅001
Missing 11 2 1 8
Consultant present 7755 (89⋅5)* 1178 (85⋅9) 2940 (90⋅9) 3637 (89⋅6) < 0⋅001
Consultant specialty < 0⋅001
Oesophagogastric 3416 (38⋅5) 560 (38⋅8) 1220 (37⋅1) 1636 (39⋅5)
HPB 1918 (21⋅6) 314 (21⋅8) 634 (19⋅3) 970 (23⋅4)
Colorectal 1958 (22⋅1) 352 (24⋅4) 831 (25⋅3) 775 (18⋅7)
Breast 348 (3⋅9) 42 (2⋅9) 137 (4⋅1) 169 (4⋅1)
Vascular 373 (4⋅2) 57 (3⋅9) 141 (4⋅3) 175 (4⋅2)
Other 863 (9⋅7) 117 (8⋅1) 327 (9⋅9) 419 (10⋅1)
Missing 33 9 3 21
Operative method < 0⋅001
Laparoscopic 8523 (95⋅7) 1343 (92⋅6) 3105 (94⋅3) 4075 (97⋅8)
Converted 297 (3⋅3) 77 (5⋅3) 152 (4⋅6) 68 (1⋅6)
Open 89 (1⋅0) 31 (2⋅1) 36 (1⋅1) 22 (0⋅5)
Hospital type < 0⋅001
Non-university 4843 (54⋅4) 687 (47⋅3) 1915 (58⋅2) 2241 (53⋅8)
University 4066 (45⋅6) 764 (52⋅7) 1378 (41⋅8) 1924 (46⋅2)
Tertiary HPB centre < 0⋅001
No 6602 (74⋅1) 941 (64⋅9) 2588 (78⋅6) 3073 (73⋅8)
Yes 2307 (25⋅9) 510 (35⋅1) 705 (21⋅4) 1092 (26⋅2)
Acute hospital < 0⋅001
No 561 (6⋅3) 13 (0⋅9) 222 (6⋅7) 326 (7⋅8)
Yes 8348 (93⋅7) 1438 (99⋅1) 3071 (93⋅3) 3839 (92⋅2)
Day case < 0⋅001
No 3077 (35⋅1) 5700 (64⋅9) 958 (29⋅2) 822 (19⋅8)
Yes 5700 (64⋅9) 39 (2⋅9) 2324 (70⋅8) 3337 (80⋅2)
Missing 132 115 11 6
Emergency cholcystectomy list < 0⋅001
No 6036 (67⋅8) 993 (68⋅4) 2225 (67⋅6) 2818 (67⋅7)
Ad hoc 984 (11⋅0) 152 (10⋅5) 403 (12⋅2) 429 (10⋅3)
Once per week 646 (7⋅3) 162 (11⋅2) 212 (6⋅4) 272 (6⋅5)
More than once per week 788 (8⋅8) 138 (9⋅5) 292 (8⋅9) 358 (8⋅6)
Elective surgery only at hospital 455 (5⋅1) 6 (0⋅4) 161 (4⋅9) 288 (6⋅9)
Nassar operative difficulty score < 0⋅001
1 3554 (40⋅2) 360 (25⋅1) 1146 (35⋅1) 2048 (49⋅5)
2 2644 (29⋅9) 374 (26⋅1) 942 (28⋅9) 1328 (32⋅1)
3 1814 (20⋅5) 423 (29⋅5) 775 (23⋅8) 616 (14⋅9)
4 821 (9⋅3) 278 (19⋅4) 397 (12⋅2) 146 (3⋅5)
Missing 76 16 33 27
IOC < 0⋅001
Not performed 7770 (87⋅9) 1121 (78⋅0) 2869 (87⋅6) 3780 (91⋅6)
Planned 965 (10⋅9) 295 (20⋅5) 354 (10⋅8) 316 (7⋅7)
Unplanned 105 (1⋅2) 22 (1⋅5) 54 (1⋅6) 29 (0⋅7)
Missing 69 13 16 40
CBD exploration 282† 99 (6⋅9) 113 (3⋅4) 70 (1⋅7) < 0⋅001
Values in parentheses are percentages. HPB, hepatobiliary; IOC, intraoperative cholangiography; CBD, common bile duct. Data missing for *244 and
†75 patients. ‡χ2 test or Fisher’s exact test, as appropriate.
emergency cholecystectomy at each hospital were calcu-
lated for all patients. Descriptive statistics were obtained
for all variables. Median values with interquartile range
(i.q.r.) are reported. The χ2 test or Fisher’s exact test,
as appropriate, was used to identify differences between
categorical variables.
To investigate the relationship between 30-day read-
mission and complication rates and the variables studied,
data were analysed using multilevel, multivariable logis-
tic regression modelling. Both 30-day readmission and
complication rates were recorded as binary outcome mea-
sures, requiring a logistic analytical approach. These data
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Table 3 Thirty-day readmission and complications according to performance of emergency, delayed or elective cholecystectomy
Emergency cholecystectomy
(n=1451)
Delayed cholecystectomy
(n=3293)
Elective cholecystectomy
(n=4165) P*
Readmissions 138 (9⋅5) 270 (8⋅2) 225 (5⋅4) <0⋅001
All complications 223 (15⋅4) 420 (12⋅8) 319 (7⋅7) < 0⋅001
Intraoperative complications
Stones spilt 222 (15⋅3) 400 (12⋅1) 224 (5⋅4) < 0⋅001
Bleeding 195 (13⋅4) 302 (9⋅2) 257 (6⋅2) < 0⋅001
Bowel injury 8 (0⋅6) 22 (0⋅7) 19 (0⋅5) 0⋅479
CBD injury 5 (0⋅3) 12 (0⋅4) 7 (0⋅2) 0⋅232
Postoperative complications
Collections 44 (3⋅0) 88 (2⋅7) 57 (1⋅4) < 0⋅001
Surgical-site infection 38 (2⋅6) 78 (2⋅4) 76 (1⋅8) 0⋅114
Pancreatitis 13 (0⋅9) 19 (0⋅6) 4 (0⋅1) <0⋅001
CBD stone 30 (2⋅1) 28 (0⋅9) 25 (0⋅6) < 0⋅001
Bile leak 32 (2⋅2) 52 (1⋅6) 37 (0⋅9) < 0⋅001
Respiratory 29 (2⋅0) 69 (2⋅1) 29 (0⋅7) < 0⋅001
Reimaging 172 (11⋅8) 300 (9⋅1) 206 (4⋅9) <0⋅001
Radiological drain 16 (1⋅1) 37 (1⋅1) 16 (0⋅4) <0⋅001
Relaparoscopy or laparotomy 7 (0⋅5) 27 (0⋅8) 27 (0⋅6) 0⋅399
30-day mortality 3 (0⋅2) 6 (0⋅2) 2 (0⋅0) 0⋅160
Values in parentheses are percentages. CBD, common bile duct. *χ2 test.
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Fig. 1 Thirty-day a readmission rate and b complication rate according to number of emergency admissions before cholecystectomy
comprise a two-level hierarchical structure, with patients
at level 1, nested within hospitals at level 2. Multilevel
(hierarchical) modelling was selected owing to the struc-
ture of the data. Patient outcomes are not independent of
each other as patients are clustered within hospitals. This
clustering introduces multilevel dependency or correlation
among patient observations that can have implications for
model parameter estimates. Because of this dependency
among observations, multilevel modelling has advantages
over other approaches, such as logistic regression analysis,
which assume that observations are independent.
Before model building, variables were investigated for
potential confounding relationships using correlation and
scatter plots. As the variables included in this study could
be viewed as being on a causal path potentially linking each
variable to the outcome, they were assessed during model
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Fig. 2 Plot examining hospital effects (residuals) and corresponding 95 per cent confidence intervals for 30-day readmissions
Table 4 Multilevel random intercept logistic regression analysis
of association between patient and surgery characteristics with
all-cause 30-day readmission following cholecystectomy
Odds ratio P
Random intercept 0⋅07 (0⋅06, 0⋅09) <0⋅001
Patient factors
Age (years)
<40 1⋅00 (reference)
40–60 0⋅78 (0⋅63, 0⋅95) 0⋅014
61–80 0⋅72 (0⋅58, 0⋅91) 0⋅005
>80 0⋅56 (0⋅33, 0⋅94) 0⋅028
ASA fitness grade
I–II 1⋅00 (reference)
II–IV 1⋅47 (1⋅14, 1⋅90) 0⋅003
Surgical factors
Surgery admission type
Delayed 1⋅00 (reference)
Emergency 0⋅91 (0⋅68, 1⋅21) 0⋅519
Elective 0⋅48 (0⋅35, 0⋅66) <0⋅001
No. of surgical admissions
0 1⋅00 (reference)
1 1⋅50 (1⋅11, 2⋅03) 0⋅009
≥2 1⋅59 (1⋅18, 2⋅14) 0⋅002
Duration of surgery (per min) 1⋅01 (1⋅00, 1⋅01) 0⋅043
Values in parentheses are 95 per cent confidence intervals.
building and none was excluded. Variable collinearity was
also tested using variance inflation factor scores.
Variables were included in the models if they were found
to be significant at the 5 per cent level. The forward and
back Collett method22 was used to select variables for
inclusion.
To investigate between-hospital variation, the random
intercept model was extended to a random coefficient
model, including each variable in turn, allowing the
factor to vary across hospitals. Results are expressed as
adjusted odds ratios (ORs) with 95 per cent confidence
intervals (c.i.).
All two-way interactions were assessed and no signifi-
cant interactions were identified in the final models. Model
testing was performed using likelihood ratio tests, Wald
tests, and residual and deviance plots. Owing to the binary
nature of the outcome data, the multilevel logistic regres-
sion model deviates from the normal assumptions that
underlie regression models and as such these were not
tested for. However, testing for the assumption of inde-
pendent co-variance structure between random effects was
not possible as no explanatory variables were included at
level 2.
Missing data accounted for 0⋅8 per cent of the data
set. Models were fitted with missed data and therefore all
available data were included.
All statistical analyses were performed using Stata®
version 12 (StataCorp, College Station, Texas, USA). The
multilevel, multivariable logistic regression modelling was
carried out in MLwiN version 2.14 (http://www.cmm.
bristol.ac.uk/MLwiN).
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Fig. 3 Plot examining hospital effects (residuals) and corresponding 95 per cent confidence intervals for 30-day complications
Results
Data were collected on 8909 patients undergoing chole-
cystectomy from 167 hospitals. Case ascertainment and
accuracy of collected data were 95⋅2 and 99⋅2 per cent
respectively, compared with information from 10 per cent
of patients checked independently against the original
medical records.
The median age of the cohort was 51 (38–64) years.
The numbers of patients undergoing emergency, delayed
and elective cholecystectomy were 1451 (16⋅3 per cent),
3293 (37⋅0 per cent) and 4165 (46⋅8 per cent) respec-
tively. A total of 3713 patients (41⋅7 per cent) had had
at least one emergency admission with acute gallbladder
disease before cholecystectomy. Elective cholecystectomy
was undertaken mainly for biliary colic, in younger women
with a low ASA fitness grade, who did not require addi-
tional radiological tests or interventions (such as MRCP
or ERCP) compared with patients who had delayed and
emergency cholecystectomy (Table 1). Patients with biliary
colic underwent elective surgery (73⋅3 per cent) more fre-
quently, whereas cholecystitis and pancreatitis were more
frequently treated by delayed cholecystectomy (53⋅0 and
64⋅0 per cent respectively). Elective cholecystectomy was
more likely to be completed laparoscopically, was less diffi-
cult as assessed by the operating surgeon, and had fewer
intraoperative complications (bile contamination, stones
spilled, bleeding, bowel and significant biliary injury),
compared with delayed and emergency cholecystectomy
(Table 2). The difference in incidence of bile duct injury,
however, did not reach statistical significance. The median
duration of an elective procedure was 60 (45–79) min com-
paredwith 65 (50–90) and 80 (60–110)min for delayed and
emergency cholecystectomy respectively.
Outcomes at 30 days
Readmission and complication rates at 30 days were 7⋅1 per
cent (633 of 8909) and 10⋅8 per cent (962 of 8909) respec-
tively (Table 3). The rates of readmission, overall complica-
tions and individual complications at 30 days were higher
in the delayed and emergency groups than in the elective
group. Both readmission and complication rates differed
according to the number of surgical admissions (Fig. 1).
Readmission rates among patients with no, one or at least
two surgical admissions before cholecystectomy were 6⋅1,
7⋅2 and 12⋅9 per cent respectively; corresponding compli-
cation rates were 8⋅9, 11⋅8 and 19⋅1 per cent. Reoperations
were more frequent following delayed cholecystectomy,
although this difference was not statistically significant.
The 30-day mortality rate was higher when cholecystec-
tomywas performed as an emergency or delayed operation,
but again this difference was not statistically significant.
Thirty-day readmission rate
The null random intercept model containing no
exploratory variables was used to test variation across the
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Table 5 Multilevel random intercept logistic regression of the
association between patient and surgery characteristics with
all-cause 30-day complications following cholecystectomy
Odds ratio P
Random intercept 0⋅06 (0⋅04, 0⋅07) <0⋅001
Patient factors
Age (years)
<40 1⋅00 (reference)
40–60 0⋅78 (0⋅65, 0⋅95) 0⋅012
60–80 0⋅98 (0⋅80, 1⋅19) 0⋅838
>80 1⋅52 (1⋅08, 2⋅16) 0⋅018
ASA fitness grade
I–II 1⋅00 (reference)
II–IV 1⋅44 (1⋅17, 1⋅78) 0⋅001
Surgical factors
Surgical admission type
Delayed 1⋅00 (reference)
Emergency 1⋅01 (0⋅80, 1⋅29) 0⋅902
Elective 0⋅61 (0⋅46, 0⋅81) <0⋅001
No. of surgical admissions
0 1⋅00 (reference)
1 1⋅36 (1⋅05, 1⋅75) 0⋅021
≥2 1⋅28 (0⋅99, 1⋅65) 0⋅055
Method of operation
Laparoscopic 1⋅00 (reference)
Open 1⋅77 (1⋅04, 3⋅01) 0⋅034
Laparoscopic converted to open 2⋅59 (1⋅91, 3⋅52) <0⋅001
Duration of surgery (per min) 1⋅01 (1⋅01, 1⋅01) 0⋅003
Level of operation difficulty (per Nassar level) 1⋅22 (1⋅12, 1⋅33) <0⋅001
Values in parentheses are 95 per cent confidence intervals.
167 hospitals, and demonstrated a statistically significant
between-hospital variance (likelihood ratio statistic 11⋅57,
P= 0⋅003). Estimates of the hospital effects obtained from
the null model showed the hospital effects in rank order
together with 95 per cent confidence intervals (Fig. 2).
Only two of 167 hospitals (1⋅2 per cent) had 30-day read-
mission rates higher than the rest. When the model was
extended to include explanatory variables, duration of
surgery and greater number of surgical admissions before
the index surgery were associated with a higher risk of
readmission, whereas there was no difference in readmis-
sions between emergency and delayed operation (Table 4).
Elective cholecystectomy, younger patients and ASA score
I–II were associated with a lower risk of readmission. The
variables included in this multilevel model accounted for
97 per cent of the detected variation. BMI, indication for
cholecystectomy and hospital-related variables were not
independently associated with readmission.
Thirty-day complication rate
The null random intercept model demonstrated significant
between-hospital variance (likelihood ratio statistic 74⋅80,
P= 0⋅003). Eleven hospitals (6⋅6 per cent) had a signifi-
cantly different 30-day complication rate from the others
(Fig. 3). When the model was extended to include explana-
tory variables, age, ASA grade, surgical admission type,
number of admissions and duration of surgery were again
associated with complications (Table 5). In addition, hav-
ing an open or a laparoscopic procedure converted to open
surgery and a greater degree of operative difficulty were
associated with a higher risk of complications. These vari-
ables accounted for 93 per cent of the detected variation.
Other patient categories, disease and hospital factors were
not independently associated with the outcomes measured.
Discussion
This study evaluated the current management and out-
comes of cholecystectomy for benign gallbladder disease
in the UK and Ireland. Readmissions and complications
were common and varied across the 167 hospitals stud-
ied. An emergency or delayed operation and greater num-
bers of surgical admissions before the index surgery were
associated with a higher risk of readmission and compli-
cations. Intraoperative features, such as difficulty, duration
and operative method, were also associated with poorer
outcomes across hospitals. Importantly, the hospital char-
acteristics analysed did not influence these associations.
Readmission and complication rates at 30 days were sim-
ilar to those reported previously. Other studies2,6,12,23–26
have described patient and hospital factors, both indepen-
dently and in combination, linked to complications and
readmissions. Factors associated with readmission or com-
plication in the present study were analysed by means of
hierarchical modelling. The advantage of this type of anal-
ysis was that it allowed the effects of patient variables on
certain outcomes to be considered independently of hospi-
tal variables that may also influence outcomes27. Age, ASA
grade, duration of surgery, operative approach and degree
of operative difficulty were all associated with worse out-
comes. as demonstrated previously25,28.
Increasing numbers of emergency admissions before
cholecystectomy were independently associated with both
readmission and complication rates here. This supports
a pathway in which definitive cholecystectomy should be
performed during the first admission. Emergency chole-
cystectomy was carried out mainly in younger patients and
those presenting with cholecystitis, whereas older patients
and those requiring further investigations tended to be dis-
charged and brought back for a delayed cholecystectomy.
Delayed cholecystectomy can result in emergency read-
missions and poorer outcomes29–33. Logistical barriers to
emergency cholecystectomy, such as lack of prompt access
to specialist investigations and emergency theatre avail-
ability, appear to explain differences in service provision.
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Hospital policy and surgeon or patient preference may
contribute to delaying cholecystectomy. Increasing the
numbers of emergency cholecystectomies by address-
ing modifiable barriers, such as reducing the number of
surgical admissions with gallbladder pathology before
cholecystectomy, would improve outcomes. This is gen-
eralizable to healthcare providers outside the UK and
Ireland.
In contrast to previous studies, there was no statisti-
cal difference in readmissions and complications when
emergency and delayed cholecystectomies were compared,
suggesting that the delayed cohort was not homogeneous.
Definitions of emergency and delayed cholecystectomy
varied in previous studies. Some considered emergency or
early cholecystectomy to comprise operations performed
within 48–72 h of symptom onset5. A population-based
study4 of 14 200 patients in Canada showed that patients
experienced fewer complications when cholecystectomy
was performed within 7 days of hospital admission. A
study3 in Switzerland demonstrated that a 6-day delay in
performing emergency cholecystectomy was associated
with a higher conversion rate (12 per cent at day 0 versus
18 per cent at day 6), more complications (5⋅7 versus 13
per cent respectively), and the reoperation rate was almost
double in the delayed compared with the emergency group
(0⋅8 versus 0⋅5 per cent).
There are limitations to the present study. The data rep-
resent a 2-month snapshot of practice and this may account
for unexpected observations, such as the inverse associa-
tion between age and risk of readmission. However, short
intensive data collection allowed surgical teams to con-
tribute meaningful numbers of patients with high levels of
accuracy and without additional resources. The number of
patients who did not undergo cholecystectomy is unknown.
It seems intuitive that those with less co-morbidity are
more likely to be offered cholecystectomy. The overall
models accounted for nearly 90 per cent of the variations
in outcomes seen across the hospitals studied, suggest-
ing the presence of other factors not characterized in this
study. Despite these limitations, the accuracy of the data set
was validated independently and it contained variables not
typically collected in similar studies.
Sweden34, Denmark35 and Switzerland25 use prospec-
tive registries of cholecystectomy for continual quality
improvement. Although this is costly and time-consuming,
the results of this prospective population-based cohort
study demonstrate that cholecystectomy following multi-
ple surgical admissions is linked to 30-day complications
and readmissions. Measuring numbers of surgical admis-
sions before cholecystectomy provides a simple quality
improvement metric. There needs to be a focus on
offering emergency rather than delayed cholecystectomy
for patients presenting with acute benign gallbladder
disease.
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